Clinical Study

Long-Term Extension Safety And Efficacy Study Of Sar442168 In Participants With Relapsing Multiple Sclerosis

Posted Date: Oct 10, 2019

  • Investigator: Lawrence Goldstick
  • Specialties: Multiple Sclerosis, Neurology
  • Type of Study: Drug

This study will look at the safety and efficacy of an investigational new drug for relapsing multiple sclerosis

Criteria:

Patients With Relapsing Multiple Sclerosis Who Have Completed The Dri15928 Study

Keywords:

Multiple Sclerosis, Btk

For More Information:

Melissa Gilchrist
9375355014
melissa.gilchrist@uchealth.com


  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.